Home
 /
Papers
 /
Molecular Biology
 /
Bacterial Schlafens mediate anti-phage defense
Preprint
Open access
V1
Top 1% · Validated by QED

Bacterial Schlafens mediate anti-phage defense

Veronica Perez Taboada, Yimo Wu, Riley Cassidy +4 more
July 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.07.24.666596
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Molecular Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

This work establishes bacterial Schlafen nucleases as ancient anti-phage effectors—modular systems cleaving tRNA to abort infection—overturning the assumption that Schlafen antiviral function is eukaryotic and tracing human tRNA-targeting immunity to prokaryotic origins.

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

Our work highlights the remarkable conservation of antiviral defenses across billions of years of evolution, from bacteria to humans. Schlafen proteins have been studied for nearly three decades for their roles in human antiviral immunity, but we found that bacteria also use Schlafen homologs to defend against bacteriophages, the viruses that infect bacteria.

”
Artem Nemudryi

QED claims analysis

Summary

Prokaryotic Schlafen proteins function as widespread modular antiviral defense systems in bacteria, where diverse sensor domains detect phage infection triggers such as tail assembly chaperones and activate a conserved ribonuclease effector domain that cleaves tRNA in the anticodon arm to mediate abortive infection, revealing that tRNA-targeting antiviral immunity represents an ancient mechanistically conserved strategy across all domains of life.

See full analysis
Main Claim 1 –

Prokaryotic Schlafen nucleases broadly protect bacteria from phages

Supporting evidence

  • Prokaryotic Schlafen defense triggers abortive infection and limits phage
  • Schlafen nuclease is an ancient immune effector conserved across life
Main Claim 2 –

T5 tail chaperone T5.142 activates RorSlfn5 defense

Supporting evidence

  • pSlfn5 homologs recognize distinct phage tail assembly chaperones
Main Claim 3 –

pSlfn5 Ig-like domain senses phage and dictates specificity

Supporting evidence

  • RorSlfn5 directly binds the T5.142 tail assembly chaperone
Main Claim 4 –

RorSlfn5 preferentially cleaves tRNA during phage infection

Supporting evidence

  • RorSlfn5 activation arrests growth ~30 minutes after trigger
  • RorSlfn5 is an RNase, generating 25–50 nt RNA fragments
  • RorSlfn5 cleaves tRNA anticodon arm, removing anticodon loop
  • RorSlfn5 tRNase activity is reconstituted in vitro and Mn-dependent

Abstract

Human Schlafen proteins restrict viral replication by cleaving tRNA, thereby suppressing protein synthesis. Although the ribonuclease domain of Schlafen proteins is conserved across all domains of life, its function in prokaryotes has remained unclear. Here, we show that prokaryotic Schlafen nucleases (pSlfns) are widespread antiviral effectors that protect bacteria from phages. These nucleases are fused to diverse protein domains that sense phage infection. We focus on a system where Schlafen nuclease is fused to a previously unknown immunoglobulin-like sensor domain and demonstrate that it recognizes T5-like phage tail assembly chaperones and cleaves both bacterial and viral tRNA, triggering abortive infection. Our findings redefine Schlafens as an ancient, mechanistically conserved family of immune effectors, revealing the deep evolutionary origin of tRNA-targeting antiviral immunity in humans.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?